Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol

Journal of Psychiatric Research

Volumn 51, Issue 1, 2014, Pages 30-36

  Yuen, Kaeli W ^a   Garner, Joseph P ^a   Carson, Dean S ^a   Keller, Jennifer ^a   Lembke, Anna ^a   Hyde, Shellie A ^a   Kenna, Heather A ^a   Tennakoon, Lakshika ^a   Schatzberg, Alan F ^a   Parker, Karen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical phenotypes; Cortisol; Gender; Major depression; Plasma oxytocin; Psychotic major depression

Indexed keywords

HYDROCORTISONE; OXYTOCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; FEMALE; HAMILTON SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; MALE; MIDDLE AGED; OXYTOCIN BLOOD LEVEL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE;

CLINICAL PHENOTYPES; CORTISOL; GENDER; MAJOR DEPRESSION; PLASMA OXYTOCIN; PSYCHOTIC MAJOR DEPRESSION;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OXYTOCIN; PSYCHIATRIC STATUS RATING SCALES; SEX CHARACTERISTICS;

EID: 84893969667     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.12.012     Document Type: Article

References (63)

1. Amico J.A., Mantella R.C., Vollmer R.R., Li X. Anxiety and stress responses in female oxytocin deficient mice. Journal of Neuroendocrinology 2004, 16:319-324.
2. Andari E., Schneider F.C., Mottolese R., Vindras P., Sirigu A. Oxytocin's fingerprint in personality traits and regional brain volume. Cerebral Cortex 2012, 10.1093/cercor/bhs328.
3. Belanoff J.K., Kalehzan M., Sund B., Ficek S.K.F., Schatzberg A.F. Cortisol activity and cognitive changes in psychotic major depression. American Journal of Psychiatry 2001, 158:1612-1616.
4. Bertsch K., Schmidinger I., Neumann I.D., Herpertz S.C. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Hormones and Behavior 2013, 63:424-429.
5. Boscaro M., Barzon L., Fallo F., Sonino N. Cushing's syndrome. Lancet 2001, 357:783-791.
6. Bruce M.L., Hoff R.A. Social and physical health risk-factors for 1st-onset major depressive disorder in a community sample. Social Psychiatry and Psychiatric Epidemiology 1994, 29:165-171.
7. Carson D.S., Guastella A.J., Taylor E.R., McGregor I.S. Abrief history of oxytocin and its role in modulating psychostimulant effects. Journal of Psychopharmacology 2013, 27:231-247.
8. Carter C.S., Pournajafi-Nazarloo H., Kramer K.M., Ziegler T.E., White-Traut R., Bello D., et al. Oxytocin: behavioral associations and potential as a salivary biomarker. Annals of the New York Academy of Sciences 2007, 1098:312-322.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV-TR Axis I disorders (Patient Edition) 1997, American Psychiatric Press, Washington, DC. SCID-I/P, 2/2001 revision ed.
10. Frasch A., Zetzsche T., Steiger A., Jirikowski G.F. Reduction of plasma oxytocin levels in patients suffering from major depression. Advances in Experimental Medicine and Biology 1995, 395:257-258.
11. Garcia F.D., Coquerel Q., Kiive E., Dechelotte P., Harro J., Fetissov S.O. Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:118-125.
12. Gold P.W., Loriaux D.L., Roy A., Kling M.A., Calabrese J.R., Kellner C.H., et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. The New England Journal of Medicine 1986, 314:1329-1335.
13. Guastella A.J., MacLeod C. Acritical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Hormones and Behavior 2012, 61:410-418.
14. Hamilton M. Arating scale for depression. Journal of Neurololgy, Neurosurgery and Psychiatry 1960, 23:56-62.
15. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Molecular Psychiatry 2009, 14:954-958.
16. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry 2003, 54:1389-1398.
17. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 1994, 28:341-356.
18. Jarrett T.M., McMurray M.S., Walker C.H., Johns J.M. Cocaine treatment alters oxytocin receptor binding but not mRNA production in postpartum rat dams. Neuropeptides 2006, 40:161-167.
19. Johns J.M., Lubin D.A., Walker C.H., Meter K.E., Mason G.A. Chronic gestational cocaine treatment decreases oxytocin levels in the medial preoptic area, ventral tegmental area and hippocampus in Sprague-Dawley rats. Neuropeptides 1997, 31:439-443.
20. Johns J.M., Noonan L.R., Zimmerman L.I., Li L., Pedersen C.A. Effects of short- and long-term withdrawal from gestational cocaine treatment on maternal behavior and aggression in Sprague-Dawley rats. Developmental Neuroscience 1997, 19:368-374.
21. Jokinen J., Chatzittofis A., Hellstrom C., Nordstrom P., Uvnas-Moberg K., Asberg M. Low CSF oxytocin reflects high intent in suicide attempters. Psychoneuroendocrinology 2012, 37:482-490.
22. Keller J., Flores B., Gomez R.G., Solvason H.B., Kenna H., Williams G.H., et al. Cortisol circadian rhythm alterations in psychotic major depression. Biological Psychiatry 2006, 60:275-281.
23. Kiecolt-Glaser J.K., Glaser R., Cacioppo J.T., Malarkey W.B. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Annals of the New York Academy of Sciences 1998, 840:656-663.
24. Kiecolt-Glaser J.K., Newton T., Cacioppo J.T., MacCallum R.C., Glaser R., Malarkey W.B. Marital conflict and endocrine function: are men really more physiologically affected than women?. Journal of Consulting and Clinical Psychology 1996, 64:324-332.
25. Knox S.S., Uvnas-Moberg K. Social isolation and cardiovascular disease: an atherosclerotic pathway?. Psychoneuroendocrinology 1998, 23:877-890.
26. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology 2004, 25:150-176.
27. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., et al. Elevated cerebrospinal-fluid levels of oxytocin in obsessive-compulsive disorder - comparison with Tourettes-syndrome and healthy controls. Archives of General Psychiatry 1994, 51:782-792.
28. Lee R., Ferris C., Van de Kar L.D., Coccaro E.F. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinology 2009, 34:1567-1573.
29. Light K.C., Grewen K.M., Amico J.A., Boccia M., Brownley K.A., Johns J.M. Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy. Addictive Behaviors 2004, 29:1541-1564.
30. Lim M.M., Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Hormones and Behavior 2006, 50:506-517.
31. Littell R.C., Stroup W.W., Freund R.J. SAS for linear models 2002, SAS Institute, Cary, NC. 4th ed.
32. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nature Reviews Neuroscience 2006, 7:126-136.
33. McGregor I.S., Bowen M.T. Breaking the loop: oxytocin as a potential treatment for drug addiction. Hormones and Behavior 2012, 61:331-339.
34. McGregor I.S., Callaghan P.D., Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. British Journal of Pharmacology 2008, 154:358-368.
35. Million T., Million C., Davis R., Grossman S. MCMI-III manual 2009, Pearson Education, Inc., Minneapolis, MN.
36. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
37. Neumann I.D., Kromer S.A., Toschi N., Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regulatory Peptides 2000, 96:31-38.
38. Ochedalski T., Subburaju S., Wynn P.C., Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. Journal of Neuroendocrinology 2007, 19:189-197.
39. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
40. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Research 2009, 169:249-252.
41. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., et al. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Research 2010, 178:359-362.
42. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Hormones and Behavior 2003, 43:60-66.
43. Pedersen C.A., Prange A.J. Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:6661-6665.
44. Pedersen C.A., Ascher J.A., Monroe Y.L., Prange A.J. Oxytocin induces maternal behavior in virgin female rats. Science 1982, 216:648-650.
45. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., et al. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophrenia Research 2011, 132:50-53.
46. Raff H., Raff J.L., Findling J.W. Late-night salivary cortisol as a screening test for Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism 1998, 83:2681-2686.
47. Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophrenia Research 2010, 124:13-21.
48. Sarnyai Z. Oxytocin and neuroadaptation to cocaine. Progress in Brain Research 1998, 119:449-466.
49. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 2007, 32:407-410.
50. Schatzberg A.F., Keller J., Tennakoon L., Lembke A., Williams G., Kraemer F.B., et al. HPA axis genetic variation, cortisol, and psychosis in major depression. Molecular Psychiatry 2013 Oct 29, [Epub ahead of print]. PMID: 24166410. 10.1038/mp.2013.129.
51. Silva S.M., Madeira M.D., Ruela C., Paula-Barbosa M.M. Prolonged alcohol intake leads to irreversible loss of vasopressin and oxytocin neurons in the paraventricular nucleus of the hypothalamus. Brain Research 2002, 925:76-88.
52. Sivukhina E.V., Dolzhikov A.A., Morozov I.E., Jirikowski G.F., Grinevich V. Effects of chronic alcoholic disease on magnocellular and parvocellular hypothalamic neurons in men. Hormone and Metabolic Research 2006, 38:382-390.
53. Strathearn L., Fonagy P., Amico J., Montague P.R. Adult attachment predicts maternal brain and oxytocin response to infant cues. Neuropsychopharmacology 2009, 34:2655-2666.
54. Strathearn L., Iyengar U., Fonagy P., Kim S. Maternal oxytocin response during mother-infant interaction: associations with adult temperament. Hormones and Behavior 2012, 61:429-435.
55. Stroud L.R., Salovey P., Epel E.S. Sex differences in stress responses: social rejection versus achievement stress. Biological Psychiatry 2002, 52:318-327.
56. Taylor S.E., Gonzaga G.C., Klein L.C., Hu P.F., Greendale G.A., Seeman T.E. Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosomatic Medicine 2006, 68:238-245.
57. Tops M., Van Peer J.M., Korf J., Wijers A.A., Tucker D.M. Anxiety, cortisol, and attachment predict plasma oxytocin. Psychophysiology 2007, 44:444-449.
58. White T., Ozel B., Jain J.K., Stanczyk F.Z. Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins. Contraception 2006, 74:293-296.
59. Witt D.M., Winslow J.T., Insel T.R. Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacology Biochemistry and Behavior 1992, 43:855-861.
60. You Z.D., Li J.H., Song C.Y., Wang C.H., Lu C.L. Chronic morphine treatment inhibits oxytocin synthesis in rats. Neuroreport 2000, 11:3113-3116.
61. Young E.A. Sex differences and the HPA axis: implications for psychiatric disease. The Journal of Gender Specific Medicine 1998, 1:21-27.
62. Young L.J. Being human: love: neuroscience reveals all. Nature 2009, 457:148.
63. Young K.A., Liu Y., Wang Z. The neurobiology of social attachment: a comparative approach to behavioral, neuroanatomical, and neurochemical studies. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2008, 148:401-410.